ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

CPT Code Changes Confuse Oncologists, Appear To Bloc Some Chemotherapy Payments

April 6, 1990

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002

NCI Awards $10 Million To States for Cervix Screening

September 27, 1974

I-131 doses highest Near Nevada Test Site, Fallout Study Finds

November 17, 1989

In Brief: The Children’s Oncology Group Is Name for Pediatric Trials Groups In Merger

June 25, 1999

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014